Learn More
Description
- Improved workflow with two modes - Analyze Now and Walk-Away mode providing test results and aiding in decision making while the patient is onsite
- Cleared for use with nasal swabs and nasopharyngeal swabs
- Reduce hands on time
- Create a flexible workflow
- Better connectivity with infowifi
- Advanced particle technology enhances sensitivity by using a proprietary process to produce highly stable, modified colloidal metal particles
- Adaptive read technology compensates for background and non-specific binding which helps improve specificity to reduce false-positive results
- Number of reads per instrument: 10,000
- Rechargeable lithium battery
- Print-enabled
Specifications
Specifications
| Description | BD Veritor™ Point-of-Care Immunoassay Analyzer |
| Clia Complexity | Waived |
| Detectable Analytes | Influenza A and B, Respiratory Syncytial Virus (RSV), Streptococcus (Group A), SARS-CoV-2 |
| Sample Type | Nasal swabs and nasopharyngeal (NP) swabs |
| Type | Point-of-Care ImmunoAssay Analyzer |
| For Use With (Application) | InfoWiFi |
| Includes | Lithium battery |
| Quantity | Each |
| Test Time | 5 to 10 min. |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.